Lauxera Growth II

About Lauxera Growth II

Paris and SF-based growth investor backing commercial-stage European healthtech companies expanding into the US. €20M–€50M checks, minority and majority. Anchored by Bpifrance, EIF, Morgan Stanley IM.

Investment Focus

Location / RegionFrance

Funding StageGrowth

Industry Focus

Biotech

Diagnostics

Digital Health

Med Tech

Investor Signals Profile

active

Sweet Spot

Commercial-stage European healthtech founder with US expansion thesis

European healthtech US expansion

growth equity

commercial-stage only

transatlantic bridge

reimbursement-driven markets

Bullish Signals

90%+ LP re-up rateblog

€520M, broke hard capblog

Morgan Stanley IM, EIF, Bpifrance anchoringblog

2 deals deployed, disciplined pacingblog

Contrarian Signals

12–15 company portfolio, high concentrationblog

US M&A market remains choppyblog

No public IRR figures disclosedblog

Founder Do's

Have €5M+ revenue before approaching

Show credible US reimbursement strategy

Be ready for deep US commercial diligence

Open to majority or minority structures

European HQ, US expansion ambition required

Founder Don'ts

Don't pitch pre-commercial or early-stage

Don't ignore US market-entry plan

Don't expect light diligence process

Key GPs & Partners

Lauxera Capital Partners Team

Partnership Group

thesis-drivenhands-onex-founder

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size€520M

Saves0

Website

Key People

Lauxera Capital Partners

Lauxera Capital Partners TeamPartnership Group